Dexmedetomidine for dyspnoea.

Humans Dexmedetomidine / therapeutic use Hypnotics and Sedatives / therapeutic use Pain Intensive Care Units Dyspnea / drug therapy
dyspnoea supportive care terminal care

Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 03 04 2020
accepted: 12 05 2020
medline: 23 10 2023
pubmed: 13 6 2020
entrez: 13 6 2020
Statut: ppublish

Résumé

Dexmedetomidine is a selective α

Identifiants

DOI: 10.1136/bmjspcare-2020-002334 PMID: 32527791
pubmed: 32527791
pii: bmjspcare-2020-002334
doi: 10.1136/bmjspcare-2020-002334
doi:

Substances chimiques

Dexmedetomidine 67VB76HONO
Hypnotics and Sedatives 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e84-e85

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Akiko Mano (A)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan akiko_mano@tmghig.jp.
ORCID: 0000-0002-3395-6741

Tomohiro Murata (T)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Kazuma Date (K)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Mitsuhiro Kawata (M)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Miyuki Sato (M)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Norie Yamashita (N)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Kimie Iino (K)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Shunei Kyo (S)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Eiichi Saito (E)

Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Dexmedetomidine for dyspnoea.
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Dexmédétomidine › Dexmedetomidine for dyspnoea.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Dépresseurs du système nerveux central › Hypnotiques et sédatifs › Dexmedetomidine for dyspnoea.
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Douleur › Dexmedetomidine for dyspnoea.
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Unités hospitalières › Unités de soins intensifs › Dexmedetomidine for dyspnoea.
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes respiratoires › Dyspnée › Dexmedetomidine for dyspnoea.